HD-OPM Archive
Topics › Lp(a)

Statins reduce events in people with high Lp(a), even though they may raise Lp(a) 5-20%

Louis Nervegna · Aug 19, 2025 · ♥ 6 reactions · 4 comments · original Facebook post
Lp(a)Statins
↻ This is a repost. The main version (highest ranked) is Statins cut heart attack and stroke risk in high Lp(a) despite raising it 5-20% · Jun 20, 2026.
AI summary & key facts

Louis argues statins are proven to lower heart attack, stroke and CV death in people with high Lp(a), since Lp(a) carries LDL cholesterol. Shared video from Stanford's Joshua Knowles explains why the 5-20% rise in Lp(a) seen in RCT meta-analyses does not matter clinically.

Statins are proven to lower risk of heart attacks, strokes, and cardiovascular mortality in people with high Lp(a).

Lp(a) lipoproteins carry LDL cholesterol. That is their primary cargo.

One of the reasons why Lp(a) is so dangerous is because it deposits LDL cholesterol inside the walls of your arteries. The apo(a) protein on the Lp(a) particle makes it particularly sticky inside the artery wall. The apo(a) protein is also prothrombotic and makes blood clots form more easily.

See this post for more explanation of this:
↪ Lp(a) carries LDL cholesterol, so LDL-C on a lab report includes Lp(a) cholesterol

The fact that Lp(a) carries LDL cholesterol is a major reason why getting your total blood level of LDL cholesterol (LDL-C) low with statins helps to cancel a lot of the risk from high Lp(a). There is less total LDL cholesterol to get stuck inside your arteries, even if a lot of that LDL cholesterol is still coming from Lp(a).

Research cited

Statins and Lp(a)

Meta-analyses of randomized controlled trials have shown that statins can raise Lp(a) levels by as much as 5-20%.

For example:

Paper · European Heart JournalEuropean Heart Journal articleacademic.oup.com

In this video, Joshua Knowles MD, PhD— a professor of cardiovascular medicine at Stanford University— explains why this does not matter clinically. Knowles is a world-renowned expert on genetic causes of high cholesterol, including high Lp(a). Knowles explains that statins are an important part of the treatment for patients with genetically high Lp(a).

Bio of Joshua Knowles:

CAP ProfilesJoshua W. Knowles | Stanford Medicinemed.stanford.edu

As Knowles alludes to in the video, there are over 25 large long-running randomized controlled trials that have demonstrated that statins lower risk for heart attacks and strokes. This includes people with high Lp(a).

↪ 25 statin RCTs: about 75 mg/dL LDL lowering cut heart attack and stroke roughly 40%

Combining data from all these 25 trials:

Lowering LDL by about 75mg/dL (1.9mmol/L) with a statin reduces the risk of having a heart attack or stroke (MACE) by about 40% on average, as compared to people taking a placebo.

7 of these 25 clinical trials were primary prevention trials— participants who never had a heart attack or stroke before. The risk reductions for the 7 primary prevention trials were even larger than the risk reductions for the 18 secondary prevention trials.

Reference for risk reduction from the 25 statin trials:
↪ 25 statin RCTs: about 75 mg/dL LDL lowering cut heart attack and stroke roughly 40%

#statinslpaHD #statinsHD #lpaHD

← newer: Cardio reduces visceral fat even without weight loss, resistolder: Lp(a) carries LDL cholesterol, just like LDL particles do →